Clinical Trial Update: Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

View source ↗

Summary

The trial tests digital PCR methods for monitoring minimal residual disease after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia (AML) | Status: RECRUITING